4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-25-061752
Director sold 23,500 shares at $48.79 ($1,146,565)
- Director acquired 23,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moukheibir Catherine Director | 2025-07-03 | Option exercise | +23,500 | 23,500 | D: show line 1 in the form | ||
| Moukheibir Catherine Director | 2025-07-03 | Sale | −23,500 | $48.79 | $1,146,565 | 0 | D: show line 2 in the form |
| Open-market sales · 23,500 sh · avg $48.79 · $1,146,565 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Moukheibir Catherine Director | 2025-07-03 | Option exercise · Option to Buy | −23,500 | 21,500 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…